Robert E. Gagnon Verastem, Inc. (VSTM) insider trading activity

Robert E. Gagnon is Director of Verastem, Inc.. Currently has a direct ownership of 34,193 shares of VSTM, which is worth approximately $238,667. The most recent transaction as insider was on Mar 17, 2025, when has been sold 284 shares (Common Stock) at a price of $6.95 per share, resulting in proceeds of $1,973. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.2K

0.82% 3M change

24.83% 12M change

Total Value Held $238,667

Robert E. Gagnon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 17 2025	SELL Open market or private sale	$1,973 $6.95 p/Share	284 Reduced 0.82%	34,193 Common Stock
Dec 19 2024	SELL Open market or private sale	$568 $4.37 p/Share	130 Reduced 0.38%	34,477 Common Stock
Dec 16 2024	SELL Open market or private sale	$1,293 $4.54 p/Share	285 Reduced 0.82%	34,607 Common Stock
Sep 19 2024	SELL Open market or private sale	$365 $2.79 p/Share	131 Reduced 0.37%	34,892 Common Stock
Sep 16 2024	SELL Open market or private sale	$803 $2.8 p/Share	287 Reduced 0.81%	35,023 Common Stock
Jun 20 2024	SELL Open market or private sale	$420 $3.21 p/Share	131 Reduced 0.37%	35,310 Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	8,333 Added 19.04%	35,441 Common Stock
Jun 17 2024	SELL Open market or private sale	$987 $3.49 p/Share	283 Reduced 1.03%	27,108 Common Stock
Mar 19 2024	SELL Open market or private sale	$1,349 $10.38 p/Share	130 Reduced 0.47%	27,391 Common Stock
Mar 18 2024	SELL Open market or private sale	$3,030 $10.71 p/Share	283 Reduced 1.02%	27,521 Common Stock
Feb 06 2024	SELL Open market or private sale	$126,094 $13.7 p/Share	9,204 Reduced 24.87%	27,804 Common Stock
Jan 12 2024	SELL Open market or private sale	$100,783 $10.95 p/Share	9,204 Reduced 19.92%	37,008 Common Stock
Dec 19 2023	SELL Open market or private sale	$1,004 $7.73 p/Share	130 Reduced 0.28%	46,212 Common Stock
Dec 18 2023	SELL Open market or private sale	$2,169 $7.64 p/Share	284 Reduced 0.61%	46,342 Common Stock
Sep 19 2023	SELL Open market or private sale	$1,279 $9.84 p/Share	130 Reduced 0.28%	46,626 Common Stock
Sep 18 2023	SELL Open market or private sale	$2,754 $9.91 p/Share	278 Reduced 0.59%	46,756 Common Stock
Jun 20 2023	SELL Open market or private sale	$1,339 $10.3 p/Share	130 Reduced 0.28%	47,034 Common Stock
Jun 16 2023	SELL Open market or private sale	$2,807 $9.92 p/Share	283 Reduced 0.6%	47,164 Common Stock
Mar 20 2023	SELL Open market or private sale	$715 $0.43 p/Share	1,664 Reduced 0.29%	569,399 Common Stock
Mar 16 2023	SELL Open market or private sale	$1,461 $0.4 p/Share	3,654 Reduced 0.64%	571,063 Common Stock
Dec 19 2022	SELL Open market or private sale	$528 $0.37 p/Share	1,429 Reduced 0.25%	574,717 Common Stock
Dec 16 2022	SELL Open market or private sale	$4,963 $0.4 p/Share	12,408 Reduced 2.11%	576,146 Common Stock
Sep 19 2022	SELL Open market or private sale	$1,523 $1.13 p/Share	1,348 Reduced 0.23%	588,554 Common Stock
Jun 21 2022	SELL Open market or private sale	$1,540 $1.14 p/Share	1,351 Reduced 0.23%	589,902 Common Stock
May 16 2022	SELL Open market or private sale	$17,126 $1.03 p/Share	16,627 Reduced 2.74%	591,253 Common Stock

Also insider at

BBLG

Bone Biologics Corp Healthcare

Director

REG

Robert E. Gagnon

Director

Needham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VSTM shares.

Notify only if

Value

Insider Trading

Get notified when an Verastem, Inc. insider buys or sells VSTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verastem, Inc.

Track Activities on VSTM

Account